Clinical Trials Directory

Trials / Completed

CompletedNCT01274702

Visual Reconstitution Therapy After Optic Neuritis

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
25 (actual)
Sponsor
Friedemann Paul · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

Incomplete remission after an optic neuritis attack is not uncommon. Visual reconstitution therapy is a software-based approach that has been shown to substantially improve residual visual field deficits in patients with pre- and postchiasmatic lesions. The primary hypothesis of this randomized, controlled clinical trial is, that visual reconstitution therapy is superior to active comparator treatment in improving the visual field after optic neuritis.

Detailed description

Patients with an acute optic neuritis (between 60 and 180 days before screening) or with residual visual deficits after a past optic neuritis are randomized in two treatment groups. Group A is instructed to perform software-based visual reconstitution therapy on a home PC daily and regularly for 30 minutes over a period of six month. Group B will perform a similarly, also software-based training program, developed to improve saccadic eye movements rather than visual fields. Patients are blinded to the respective treatment.

Conditions

Interventions

TypeNameDescription
OTHERVisual Reconstitutions Therapy
OTHERSaccadic Eye Movement Training

Timeline

Start date
2010-05-01
Primary completion
2013-03-01
Completion
2013-03-01
First posted
2011-01-11
Last updated
2021-07-29

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT01274702. Inclusion in this directory is not an endorsement.